Monte Rosa Therapeutics (GLUE)
(Delayed Data from NSDQ)
$3.98 USD
+0.04 (1.02%)
Updated Aug 12, 2024 03:59 PM ET
After-Market: $3.97 -0.01 (-0.25%) 7:58 PM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.49 |
EPS Last Quarter | -0.43 |
Last EPS Surprise | 14.00% |
ABR | 1.00 |
Earnings ESP
|
10.77% |
---|---|
Current Year | -1.93 |
Next Year | -1.70 |
EPS (TTM) | -2.24 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.20M | 4.24M | 9.06M | 12.81M |
# of Estimates | 3 | 3 | 4 | 3 |
High Estimate | 4.44M | 7.27M | 16.67M | 17.77M |
Low Estimate | 1.00M | 1.00M | 1.10M | 4.00M |
Year ago Sales | 0.00M | 0.00M | NA | 9.06M |
Year over Year Growth Est. | NA | NA | NA | 41.47% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.48 | -0.47 | -1.92 | -1.75 |
# of Estimates | 4 | 4 | 4 | 4 |
Most Recent Consensus | -0.34 | -0.33 | -1.56 | -1.16 |
High Estimate | -0.34 | -0.33 | -1.56 | -1.16 |
Low Estimate | -0.58 | -0.52 | -2.13 | -2.26 |
Year ago EPS | -0.70 | -0.58 | -2.63 | -1.92 |
Year over Year Growth Est. | 31.43% | 18.97% | 27.00% | 8.98% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.48 | -0.47 | -1.92 | -1.75 |
7 Days Ago | -0.48 | -0.47 | -1.92 | -1.75 |
30 Days Ago | -0.48 | -0.47 | -1.92 | -1.75 |
60 Days Ago | -0.48 | -0.47 | -1.92 | -1.75 |
90 Days Ago | -0.58 | -0.53 | -2.16 | -2.07 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.48 | -0.47 | -1.92 | -1.75 |
Zacks Consensus Estimate | -0.48 | -0.47 | -1.92 | -1.75 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.43 | -0.53 | -0.58 | -0.70 | NA |
Estimate | -0.50 | -0.56 | -0.57 | -0.75 | NA |
Difference | 0.07 | 0.03 | -0.01 | 0.05 | 0.04 |
Surprise | 14.00% | 5.36% | -1.75% | 6.67% | 6.07% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more